Corporate Overview

Compugen is a clinical-stage drug discovery and development company utilizing a broadly applicable, predictive computational discovery platform to identify novel drug targets and new biological pathways and develop therapeutics in the field of cancer immunotherapy. Recognizing the potential of immuno-oncology to shift the cancer treatment landscape, we chose to focus on the discovery of new drug targets to extend the reach of cancer immunotherapies to new patient populations.

learn more

Featured Presentation

Latest Events

view all events